Article metrics

Use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report

 

Online download statistics by month:

Online download statistics by month: to

AbstractFullPdf
Total000